LISA BALFE: Open Payments
NPI 1720469026 · WELLINGTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,738 in 211 payments from 45 companies in 2025. Trend: 2023 $2,787 · 2024 $4,286 · 2025 $4,738
Food & beverage: $4,287Education: $451
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 25 | $422 |
| Janssen Biotech, Inc. | 17 | $354 |
| Merck Sharp & Dohme LLC | 13 | $325 |
| Incyte Corporation | 10 | $318 |
| GENZYME CORPORATION | 12 | $267 |
| Daiichi Sankyo Inc. | 10 | $258 |
| GlaxoSmithKline, LLC. | 12 | $245 |
| Novartis Pharmaceuticals Corporation | 15 | $240 |
| Celgene Corporation | 10 | $191 |
| SEAGEN INC. | 2 | $187 |
Products named: KEYTRUDA, REBLOZYL, Enhertu, JAKAFI, JEMPERLI, SARCLISA, ELREXFIO, TAGRISSO.
Industry payments across FL — which companies pay providers there.
